- Home
- BWAY vs MCR Comparison
BWAY vs MCR Comparison
Compare BWAY & MCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- MCR
- Stock Information
- Founded
- BWAY 2003
- MCR 1989
- Country
- BWAY Israel
- MCR United States
- Employees
- BWAY N/A
- MCR N/A
- Industry
- BWAY Medical/Dental Instruments
- MCR Trusts Except Educational Religious and Charitable
- Sector
- BWAY Health Care
- MCR Finance
- Exchange
- BWAY Nasdaq
- MCR Nasdaq
- Market Cap
- BWAY 280.7M
- MCR 265.5M
- IPO Year
- BWAY 2019
- MCR N/A
- Fundamental
- Price
- BWAY $15.77
- MCR $6.53
- Analyst Decision
- BWAY Strong Buy
- MCR
- Analyst Count
- BWAY 2
- MCR 0
- Target Price
- BWAY $18.00
- MCR N/A
- AVG Volume (30 Days)
- BWAY 78.9K
- MCR 66.7K
- Earning Date
- BWAY 11-11-2025
- MCR 01-01-0001
- Dividend Yield
- BWAY N/A
- MCR 8.52%
- EPS Growth
- BWAY 515.14
- MCR N/A
- EPS
- BWAY 0.11
- MCR 0.38
- Revenue
- BWAY $46,084,000.00
- MCR N/A
- Revenue This Year
- BWAY $339.49
- MCR N/A
- Revenue Next Year
- BWAY $21.74
- MCR N/A
- P/E Ratio
- BWAY $55.73
- MCR $16.61
- Revenue Growth
- BWAY 26.50
- MCR N/A
- 52 Week Low
- BWAY $7.70
- MCR $5.63
- 52 Week High
- BWAY $16.25
- MCR $6.70
- Technical
- Relative Strength Index (RSI)
- BWAY 67.06
- MCR 71.10
- Support Level
- BWAY $15.32
- MCR $6.35
- Resistance Level
- BWAY $16.25
- MCR $6.53
- Average True Range (ATR)
- BWAY 0.59
- MCR 0.05
- MACD
- BWAY -0.07
- MCR 0.01
- Stochastic Oscillator
- BWAY 70.25
- MCR 97.83
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.